Annual Operating Expenses
$89.34 M
+$17.88 M+25.02%
December 31, 2022
Summary
- As of February 10, 2025, IMPL annual total operating expenses is $89.34 million, with the most recent change of +$17.88 million (+25.02%) on December 31, 2022.
- During the last 3 years, IMPL annual operating expenses has risen by +$47.77 million (+114.94%).
Performance
IMPL Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Expenses
$15.60 M
-$3.86 M-19.85%
September 1, 2023
Summary
- As of February 10, 2025, IMPL quarterly total operating expenses is $15.60 million, with the most recent change of -$3.86 million (-19.85%) on September 1, 2023.
- Over the past year, IMPL quarterly operating expenses has dropped by -$7.21 million (-31.60%).
Performance
IMPL Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
IMPL Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.0% | -31.6% |
| 3 y3 years | +114.9% | +73.4% |
| 5 y5 years | +114.9% | +59.1% |
IMPL Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -20.0% | -37.7% | at low |
| 5 y | 5-year | at high | -53.5% | -37.7% | -42.3% |
| alltime | all time | at high | -53.5% | -37.7% | -42.3% |
Impel Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $15.60 M(-19.8%) |
| Jun 2023 | - | $19.47 M(-22.3%) |
| Mar 2023 | - | $25.04 M(+19.1%) |
| Dec 2022 | $89.34 M(+25.0%) | $21.03 M(-7.8%) |
| Sep 2022 | - | $22.81 M(+3.5%) |
| Jun 2022 | - | $22.05 M(-6.0%) |
| Mar 2022 | - | $23.45 M(-3.9%) |
| Dec 2021 | $71.46 M | $24.39 M(+9.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $22.27 M(+49.1%) |
| Jun 2021 | - | $14.94 M(+51.4%) |
| Mar 2021 | - | $9.87 M(-27.3%) |
| Dec 2020 | $45.33 M(+9.1%) | $13.57 M(+50.8%) |
| Sep 2020 | - | $9.00 M(-30.6%) |
| Jun 2020 | - | $12.96 M(+32.2%) |
| Mar 2020 | - | $9.81 M |
| Dec 2019 | $41.57 M | - |
FAQ
- What is Impel Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals annual operating expenses year-on-year change?
- What is Impel Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals quarterly operating expenses year-on-year change?
What is Impel Pharmaceuticals annual total operating expenses?
The current annual operating expenses of IMPL is $89.34 M
What is the all time high annual operating expenses for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high annual total operating expenses is $89.34 M
What is Impel Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, IMPL annual total operating expenses has changed by +$17.88 M (+25.02%)
What is Impel Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of IMPL is $15.60 M
What is the all time high quarterly operating expenses for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high quarterly total operating expenses is $25.04 M
What is Impel Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, IMPL quarterly total operating expenses has changed by -$7.21 M (-31.60%)